<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kinda M. Al-Taee</style></author><author><style face="normal" font="default" size="100%">Luay A. Al-Helaly</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Hydrogen Sulfide and Cystathionine γ–Lyase with Oxidants and Antioxidants Levels for Patients with Epilepsy Diseases</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Cystationine γ–lyase</style></keyword><keyword><style  face="normal" font="default" size="100%">Epilepsy</style></keyword><keyword><style  face="normal" font="default" size="100%">Hydrogen sulfide</style></keyword><keyword><style  face="normal" font="default" size="100%">Oxidative stress</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">319-322</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;The research includes studying the levels of hydrogen sulphide (H2S) and cystathionine γ–lyase (CSE) with some oxidants and antioxidants in the serum of patients with epilepsy disease in Mosul city which include: malondialdehyde (MDA), peroxynitrite (ONOO-), glutathione (GSH), total bilirubin (TSB), albumin (Alb) and uric acid (UA), were measured in the patient group who suffered from epilepsy disease in Mosul city, Samples reached (116), which included: (56) samples for epilepsy patients group, and (60) for control group. The results showed there was a significant decrease in the levels of H2S, CSE, GSH, and TSB and a significant increase in the levels of MDA, ONOO-, Alb and UA in serum for epilepsy patients when Compared with the control group. The study concluded that H2S gas produced within the body and CSE suffer from low levels within the body, and they also decrease with the increase in the duration of the disease as a result of their use as protective functions in the body against epilepsy disease and developing it, by observing the levels of oxidants and antioxidants compounds and stimulating the body to increase their levels (H2S, and CSE) in various ways can lead to improving the health condition of patients.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">319</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Kinda M. Al-Taee&lt;sup&gt;1&lt;/sup&gt;, Luay A. Al- Helaly&lt;sup&gt;2,*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Chemistry, College of Education for Pure Science, University of Mosul, Mosul, IRAQ.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Chemistry, College of Science, University of Mosul, Mosul, IRAQ.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wardah Rahmatul Islamiyah</style></author><author><style face="normal" font="default" size="100%">Nasronudin</style></author><author><style face="normal" font="default" size="100%">Abdulloh Machin</style></author><author><style face="normal" font="default" size="100%">Iin Ernawati</style></author><author><style face="normal" font="default" size="100%">Yunita Dwi Tanti</style></author><author><style face="normal" font="default" size="100%">Nur Jaya</style></author><author><style face="normal" font="default" size="100%">Farah Medina</style></author><author><style face="normal" font="default" size="100%">Fathia Faza Rahmadanita</style></author><author><style face="normal" font="default" size="100%">Paulus Sugianto</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Analysis of The Effect of Leptin, AMPK, Adiponectin, and NPY Markers on Changes in Body Weight of Childhood Epileptic Using Valproic Acid Monotherapy</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Adiponectin</style></keyword><keyword><style  face="normal" font="default" size="100%">AMPK</style></keyword><keyword><style  face="normal" font="default" size="100%">Childhood.</style></keyword><keyword><style  face="normal" font="default" size="100%">Epilepsy</style></keyword><keyword><style  face="normal" font="default" size="100%">Leptin</style></keyword><keyword><style  face="normal" font="default" size="100%">NPY</style></keyword><keyword><style  face="normal" font="default" size="100%">Valproic acid</style></keyword><keyword><style  face="normal" font="default" size="100%">Weight gain</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">150-153</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction&lt;/strong&gt;: Epilepsy is a neurological disorder that occurs due to abnormal neurons in the brain and an imbalance between excitation and inhibition in the central nervous system. The first line of OAE in children is VPA (Valproate Acid). However, long-term use can cause weight gain with a frequency of 10-70%. The underlying mechanism of weight gain in patients remains unclear. &lt;strong&gt;Purpose: &lt;/strong&gt;This study aimed to analyze the relationship between levels of biomarkers AMPK, NPY, Leptin, and Adiponectin on changes in body weight in patients with epileptic seizures using VPA monotherapy. Method: This study is an observational cohort design. Data collection in April-June 2019. Inclusion criteria were children aged 2-10 years who used VPA requirement less than two years, not taking any drugs that affect body weight, not diagnose systemic lupus, nephrotic syndrome, and diabetes mellitus. Bodyweight and all biomarkers measurement on subjects who came to the clinic at the time of study and at least after one month of taking VPA. A total of 17 subjects participated in this study.&lt;strong&gt; Result: &lt;/strong&gt;The results of the statistical multivariate analysis test of VPA dosage on changes in body weight and biomarker levels found that Leptin, AMPK, Adiponectin did not significantly increase in body weight (p&amp;gt;0.05), but NPY significant increase in body weight (p&amp;lt;0.05). &lt;strong&gt;Conclusion:&lt;/strong&gt; NPY is the most potent for appetite enhancing, preferential effect on carbohydrate intake, weight regulation, energy storage, and expenditure. Increase production of NPY, there is an increase in energy intake and then increases fat storage and body weight.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">150</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Wardah Rahmatul Islamiyah1&lt;sup&gt;,2&lt;/sup&gt;, Nasronudin&lt;sup&gt;3,4,*&lt;/sup&gt;, Abdulloh Machin&lt;sup&gt;2&lt;/sup&gt;, Iin Ernawati&lt;sup&gt;5&lt;/sup&gt;, Yunita Dwi Tanti&lt;sup&gt;6&lt;/sup&gt;, Nur Jaya&lt;sup&gt;7&lt;/sup&gt;, Farah Medina&lt;sup&gt;8&lt;/sup&gt;, Fathia Faza Rahmadanita&lt;sup&gt;9&lt;/sup&gt;, Paulus Sugianto&lt;sup&gt;2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Neurology, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Universitas Airlangga Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Departement of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Akademi Farmasi Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Ngudi Waluyo Hospital Wlingi Blitar, INDONESIA. 7Budi Agung Hospital, Palu, INDONESIA. 8Oncology Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;9&lt;/sup&gt;Faculty of Medicine and Health Science Maulana Malik Ibrahim State Islamic University Malang, Malang, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Oscar Herrera-Calderon</style></author><author><style face="normal" font="default" size="100%">Ricardo Ángel Yuli-Posadas</style></author><author><style face="normal" font="default" size="100%">Johnny Aldo Tinco-Jayo</style></author><author><style face="normal" font="default" size="100%">Edwin Enciso-Roca</style></author><author><style face="normal" font="default" size="100%">César Franco-Quino</style></author><author><style face="normal" font="default" size="100%">Victor Chumpitaz-Cerrate</style></author><author><style face="normal" font="default" size="100%">Linder Figueroa-Salvador</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Neuroprotective Effect of Sacha Inchi Oil (Plukenetia volubilis L.) in an Experimental Model of Epilepsy</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Convulsion</style></keyword><keyword><style  face="normal" font="default" size="100%">Epilepsy</style></keyword><keyword><style  face="normal" font="default" size="100%">Omega</style></keyword><keyword><style  face="normal" font="default" size="100%">Pentylenetetrazole</style></keyword><keyword><style  face="normal" font="default" size="100%">Plukenetia Volubilis</style></keyword><keyword><style  face="normal" font="default" size="100%">Sacha inchi</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">1591-1596</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Experimental studies have demonstrated that fatty acids such as omega 3 and 6 have anti-inflammatory, anticonvulsant, cardio protective and anti-tumor effects. &lt;strong&gt;Objective:&lt;/strong&gt; The main objective was to determine the protective effect of sacha inchi oil on pentylenetetrazoleinduced seizures in albino mice. &lt;strong&gt;Material and Methods: &lt;/strong&gt;Thirty male Balb/C albino mice of 8 weeks of age were purchased from the National Institute of Health (Lima-Peru). The animals were divided into 5 groups of 6 animals each one. Group I: Control; PTZ (pentylenetetrazole 80 mg / kg, s.c.). II: PTZ + Diazepam (1 mg / kg; s.c.). Group III, IV, V: PTZ + sacha inchi oil at single doses of 250, 500, 1000 mg / kg respectively orally. Sacha inchi oil was administered 30 minutes before induction of seizures by PTZ. Next, various parameters such as latency, seizure frequency, duration and score were scored according to Racine scale. The program Graph Pad Prism v.4 was used for statistical analysis. &lt;strong&gt;Results: &lt;/strong&gt;As result, the experimental group treated with sacha inchi oil at maximum dose of 1000 mg/kg showed better results in response to PTZ induced seizure; low levels of seizures, frequency and duration (&lt;em&gt;P&lt;/em&gt;&amp;lt;0.001; ANOVA, &lt;em&gt;P&lt;/em&gt; &amp;lt;0.001 Post-hoc Dunnett test). &lt;strong&gt;Conclusion: &lt;/strong&gt;It is concluded that Sacha inchi oil presented anticonvulsant effect at the highest doses tested being very similar to Diazepam. The main mechanism could be by reducing free radical and improving GABA levels in the brain.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1591</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Oscar Herrera-Calderon&lt;sup&gt;1,*&lt;/sup&gt;, Ricardo Ángel Yuli-Posadas&lt;sup&gt;2&lt;/sup&gt;, Johnny Aldo Tinco-Jayo&lt;sup&gt;3&lt;/sup&gt;, Edwin Enciso-Roca&lt;sup&gt;3&lt;/sup&gt;, César Franco- Quino&lt;sup&gt;4&lt;/sup&gt;, Victor Chumpitaz- Cerrate&lt;sup&gt;5&lt;/sup&gt;, Linder Figueroa- Salvador&lt;sup&gt;6 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty of Pharmacy and Biochemistry, Universidad Nacional Mayor de San Marcos, Lima, PERU.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Universidad Continental, Huancayo, PERU.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Faculty of Health Sciences, Universidad Nacional de San Cristóbal de Huamanga, Ayacucho, PERU.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, PERU.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Laboratory of Pharmacology, Universidad Científica Del Sur, Lima, PERU. 6School of Medicine, Universidad Peruana de Ciencias Aplicadas, Lima PERU.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;School of Medicine, Universidad Peruana de&amp;nbsp;Ciencias Aplicadas, Lima PERU.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Anjana Goel</style></author><author><style face="normal" font="default" size="100%">Aditya Saxena</style></author><author><style face="normal" font="default" size="100%">Ashok Kumar Bhatia</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antiepileptic Effect of Nux vomica, Homeopathic Remedy, Against Strychnine-Induced Seizers</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anticonvulsant</style></keyword><keyword><style  face="normal" font="default" size="100%">Epilepsy</style></keyword><keyword><style  face="normal" font="default" size="100%">Nux vomica</style></keyword><keyword><style  face="normal" font="default" size="100%">Strychnine</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">January 2018</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://fulltxt.org/article/473</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">245-248</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Objective:&lt;/strong&gt; To investigate the antiepileptic effect of homeopathic remedy Nux vomica on mice and its comparison with standard therapeutic diazepam. &lt;strong&gt;Methods:&lt;/strong&gt; BALB-c mice were taken and divided into three groups comprising ten mice in each group. The first group was treated as control; the second group received standard therapeutics (diazepam, i.p.) and the third group received Nux vomica CH7. All groups were treated with strychnine intra peritoneally. Following parameters were observed; start time of convulsions, the number of animals had convulsions, and survival time until death. &lt;strong&gt;Results:&lt;/strong&gt; Nux vomica CH7 homeopathic preparation was found effective in suspending onset of convulsions (&lt;em&gt;P&lt;/em&gt;˂ 0.01), and extending survival time until death (&lt;em&gt;P&lt;/em&gt;˂ 0.01) in comparison to control mice. It also increased percentage survival in comparison to control as well as diazepam treated animals. &lt;strong&gt;Conclusion:&lt;/strong&gt; Our study demonstrated efficacy of Nux vomica in epilepsy management.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">245</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Anjana Goel&lt;sup&gt;1&lt;/sup&gt;*, Aditya Saxena&lt;sup&gt;2&lt;/sup&gt;, Ashok Kumar Bhatia&lt;sup&gt;3 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Biotechnology, Institute of Applied Sciences and Humanities, GLA University, 17Km stone, NH#2, Mathura-Delhi Road, PO Chaumuhan, Mathura-281406(U.P.), INDIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Biotechnology, Institute of Applied Sciences and Humanities, GLA University, Mathura, INDIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Biotechnology, Institute of Applied Sciences and Humanities, GLA University, Mathura, INDIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">A. Babalola Kadiri,</style></author><author><style face="normal" font="default" size="100%">O. Mawoussi Agboola,</style></author><author><style face="normal" font="default" size="100%">F. Olatunde. Fashina.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Ethnobotanical survey and phyto-anatomical studies of some common plants used for the treatment of epilepsy in some rural areas of South west Nigeria</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Epilepsy</style></keyword><keyword><style  face="normal" font="default" size="100%">Phytochemistry</style></keyword><keyword><style  face="normal" font="default" size="100%">Plant anatomy</style></keyword><keyword><style  face="normal" font="default" size="100%">south-west Nigeria</style></keyword><keyword><style  face="normal" font="default" size="100%">tropical forestv</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">18th Feb,2014</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">6</style></volume><pages><style face="normal" font="default" size="100%">96-102</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Aim:&lt;/strong&gt; To survey some areas in the southwest Nigeria where epilepsy is treated with plant extracts and determine the commonest plant species that are used, for pharmacognostic analysis. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; Open-ended and semi-structured interviews were conducted for information from traditional medicine practitioners. Plant names given were authenticated in the herbarium and phytochemical and anatomical analyses were conducted on the plant parts that are used for treatment using standard approaches.&lt;strong&gt; Results:&lt;/strong&gt; Fifty practitioners were interviewed and they gave 17 different plants; out of these, the 5 commonest ones were investigated. The plants are either used individually or in combination with other plant(s). Services may be rendered freely or by collecting a token which is supernaturally believed to have negative consequences. The practitioners engaged in out-patient and in-patient services and patients are usually totally cured. There are also some inexplicable practices such as oracle visitation, incantations etc. A total of 30 patients have been cured in the last decade by each practitioner. Saponin, steroids, tannins, flavonoids, phlobatannins and alkaloids were isolated using three different media (methanol, petroleum ether and water) and diagnostic anatomical characters of the leaf epidermis, fruit wall, bark and root of the plants are presented in a single account for the first time in the country. The plants studied were &lt;em&gt;Newbouldia laevis&lt;/em&gt;, &lt;em&gt;Securidaca longipedunculata&lt;/em&gt;, &lt;em&gt;Tetrapleura tetraptera&lt;/em&gt;, &lt;em&gt;Nicotiana tabacum&lt;/em&gt; and &lt;em&gt;Senna occidentalis&lt;/em&gt;.&lt;strong&gt; Conclusion:&lt;/strong&gt; The phytochemicals found are suggestive of the underlying medicinal potency of the plants and future work will help to establish the most active principles which will lead to development of drugs for treating the disease. The diagnostic anatomical characters can be employed in resolving doubts especially when the plant materials are in fragments. The least mentioned plant species can be saved from harvesting to conserve the rich flora diversity in the country.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Key words:&lt;/strong&gt; Epilepsy, phytochemistry, plant anatomy, south-west Nigeria, tropical forest.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">96</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;A. Babalola Kadiri&lt;sup&gt;a&lt;/sup&gt;, O. Mawoussi Agboola&lt;sup&gt;a&lt;/sup&gt; and F. Olatunde. Fashina&lt;/strong&gt;&lt;sup&gt;&lt;strong&gt;b&lt;/strong&gt;&lt;/sup&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;a&lt;/sup&gt;Department of Botany, University of Lagos, Akoka, Nigeria&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;b&lt;/sup&gt;Laboratory Services Unit, Nigerian Natural Medicine Development Agency, Lagos Nigeria.&lt;/p&gt;</style></auth-address></record></records></xml>